TP034/#1534 Randomized phase III trial on niraparib-TSR-042 (Dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, primary peritoneal cancer platinum resistant patients: nitche trial(MITO 33)

Authors :: Vanda Salutari
Lucia Musacchio
Sandro Pignata
Elena Ioana Braicu
David Cibula
Nicoletta Colombo
Jean-Sébastien Frenel
Flora Zagouri
Floriana Camarda
Serena Giolitto
Elena Giudice
Maria Teresa Perri
Giovanni Scambia
Domenica Lorusso
Source :: E-Posters (Trials In Progress).
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools